|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02921 JINHAI MED TECH
Nominal 
1.540 -0.160 (-9.412%) | 2023/12 - Final SGD(K$) | %Chg (Compare to Final) | 2022/12 SGD(K$) | 2021/12 HKD(K$) | 2021/12 SGD(K$) | 2020/12 HKD(K$) | |
| Turnover | 45,644 | 104.865% | 22,280 | 3,159,240 | 21,896 | 3,029,046 |
| Cost of Sales | (33,615) | 176.348% | (12,164) | -- | (14,169) | -- |
| Gross Profit | 12,029 | 18.911% | 10,116 | -- | 7,727 | -- |
| 2023/12 - Final SGD(K$) | %Chg (Compare to Final) | 2022/12 SGD(K$) | 2021/12 HKD(K$) | 2021/12 SGD(K$) | 2020/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | 37 | -- | (140,493) | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 3,185 | 0 | (5,041) | |
| Profit / (Loss) before Taxation | (3,217) | -- | 784 | (540,966) | (62) | (1,620,851) | |
| Taxation | (895) | 33.982% | (668) | (84,272) | (435) | 124,358 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 971 | 175.852% | 352 | 169,037 | 252 | 459,450 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (3,141) | -- | 468 | (456,201) | (246) | (1,037,043) | |
| 2023/12 - Final SGD(K$) | %Chg (Compare to Final) | 2022/12 SGD(K$) | 2021/12 HKD(K$) | 2021/12 SGD(K$) | 2020/12 HKD(K$) | |
| Net Finance Costs / (Income) | 165 | 122.973% | 74 | (26,731) | 130 | 8,688 |
| Depreciation & Amortisation | 4,102 | -6.475% | 4,386 | 398,153 | 5,366 | 407,752 |
| Directors' Emoluments | 643 | -29.263% | 909 | 20,499 | 1,163 | 18,801 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -0.063 | -- | 0.010 | -91.400 | -0.005 | -207.700 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.002) | -- | 0.003 | (0.036) | 0.003 | (0.148) |
| NBV per share ($) | 0.007248 | -- | 0.004953 | 8.095556 | 0.004934 | 8.825459 |
| Remarks: | Real time quote last updated: 20/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | SGD -6,043,000 |
| %Change | -- |
| EPS / (LPS) | SGD -0.001 |
| NBV Per Share ($) | SGD 0.007 |